SKLB1002
CAS: 1225451-84-2
Ref. 3D-AZB45184
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar | |
250mg | A consultar |
Información del producto
SKLB1002 is a molecule that has been shown to have potent antitumor activity. It inhibits the proliferation of endothelial cells and slows the growth of tumor vasculature. SKLB1002 also inhibits the production of adenosine-5'-diphosphate (ADP) ribose, which may be due to its ability to inhibit protein kinase A. SKLB1002 is currently being tested as a potential cancer drug in animal models and human cells in tissue culture. The effective dose for SKLB1002 is not yet known, but it has significant cytotoxicity against certain tumor xenografts in cell culture and causes significant cytotoxicity in cancer tissues.
Propiedades químicas
Consulta técnica sobre: 3D-AZB45184 SKLB1002
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.